Jackson Ryan S, Schlarman Thomas C, Hubble William L, Osman Medhat M
Division of Nuclear Medicine, Department of Internal Medicine, School of Medicine, St. Louis University, St. Louis, Missouri 63110, USA.
J Nucl Med Technol. 2006 Mar;34(1):29-33.
Recently, the use of 18F-FDG PET has progressed rapidly as a standard diagnostic imaging tool in many types of cancer. The purpose of this study was to evaluate the patterns and prevalence of muscle uptake as a result of muscle activity shortly before the 18F-FDG injection or during the uptake phase.
From October 2002 to October 2003, whole-body 18F-FDG PET scans (4-min emission and 3-min transmission per bed position) were performed on 1,164 patients with known or suspected malignancy. Images were acquired on a dedicated PET scanner 45-60 min after an intravenous injection of a weight-adjusted dose of 7.4 MBq/kg (0.2 mCi/kg) with a maximum of 925 MBq (25 mCi) 18F-FDG. A log of any nonphysiologic muscle activity during the uptake phase or reported excessive muscle activity the day before scanning was kept by the technologists. In addition, PET scans were reviewed retrospectively to evaluate any undesirably increased muscle uptake.
A total of 146 of 1,164 patients (12.5%) had excessively increased muscle uptake detected on the PET scan that corresponded to the technologists' notes of muscle activity during the uptake phase or before 18F-FDG injection. Encountered patterns of muscle uptake due to muscle activity included uptake in neck, secondary to neck strain from being on a stretcher; masseter, secondary to chewing gum; vocal cords, secondary to speaking; chest wall, secondary to labored breathing; forearms and hands, secondary to reading; and lower extremities, secondary to nervous tapping of the feet.
Undesirably increased physiologic muscle uptake is frequently encountered on 18F-FDG PET scans. In this study, 12.5% of patients were affected. It is prudent to instruct the patient to avoid any excessive physical activity at least 48 h before injection as well as to not exert muscle activity during the uptake phase. Furthermore, a record should be kept by the technologist of any observed excessive muscle activity during the uptake phase and reported to the reading physician-thus, eliminating a potential source of false-positive findings on interpreting PET scans.
最近,18F-FDG PET作为多种癌症的标准诊断成像工具,其应用迅速发展。本研究的目的是评估在注射18F-FDG前不久或摄取阶段因肌肉活动导致的肌肉摄取模式及发生率。
2002年10月至2003年10月,对1164例已知或疑似恶性肿瘤患者进行全身18F-FDG PET扫描(每个床位位置发射4分钟、透射3分钟)。静脉注射按体重调整剂量7.4 MBq/kg(0.2 mCi/kg)、最大925 MBq(25 mCi)的18F-FDG后45 - 60分钟,在专用PET扫描仪上采集图像。技术人员记录摄取阶段任何非生理性肌肉活动或扫描前一天报告的过度肌肉活动。此外,对PET扫描进行回顾性分析,以评估任何不期望出现的肌肉摄取增加情况。
1164例患者中有146例(12.5%)在PET扫描中发现肌肉摄取过度增加,这与技术人员记录的摄取阶段或注射18F-FDG前的肌肉活动情况相符。因肌肉活动导致的肌肉摄取模式包括:颈部摄取,继发于躺在担架上引起的颈部拉伤;咬肌摄取,继发于嚼口香糖;声带摄取,继发于说话;胸壁摄取,继发于呼吸费力;前臂和手部摄取,继发于阅读;下肢摄取,继发于脚部紧张轻拍。
18F-FDG PET扫描中经常会出现不期望的生理性肌肉摄取增加。在本研究中,12.5%的患者受到影响。谨慎的做法是指导患者在注射前至少48小时避免任何过度体力活动,并在摄取阶段不要进行肌肉活动。此外,技术人员应记录摄取阶段观察到的任何过度肌肉活动,并报告给阅片医生,从而消除PET扫描解读中潜在的假阳性结果来源。